l Materials and methods
Blood from 15 newborn infants was collected by puncture of the umbilical cord vein using a disposable syringe. For control blood from the cubital vein of normal adults was taken. The samples were tested by thromboelastography (TEG). From each child or control person two samples were tested: One without and the other after addition of 2.5 units urokinase (MOCHIDA, Tokyo, Japan) per ml. The concentration of the plasmin inhibitors a 2 -macroglobulin, o^-aiititrypsin and antithrombin III prior to and after the addition of urokinase was measured using M-partigen-plates (Behringwerke, Marburg, West-Germany).
Case report
InfantrM.I. 92380g. 37 week premature delivery, SFD (Small for date baby). APGAR score 5. shake test l/2(+);atbirthactualpH 7.25. A catheter was inserted into the umbilical cord vein, and bicarbonate therapy etc. was initiated. Six hours after birth, the respiratory rate was increased to 80 or 90 per minute.
T.E.G diagram showed a possible hypercoagulability, and at that time a r antitrypsin and antithrombin III, were decreased (Fig. 3) . Ten hours after birth severe cyanosis appeared followed by alveolar collapse and the child died. During the course of events, we followed the change of T.E.G., Plateletaggregation, antithrombin III, a r antitrypsin, a 2 -macroglobulin. We noted that throughout the entire course very little change was seen in a 2 -macroglobulin, but the deciease of cq-antitrypsin and antithrombin III was remarkable. At autopsy one found that the pulmonary hyaline membrane was complicated by pulmonary hemorrhage.
Results
13 out of 15 blood samples from normal newborn infants showed prior to and after addition of urokinase thrombelastogram patterns characteristic for consumption coagulopathy (Fig. 5) , the T.E.G. of blood samples from adults showed no such patterns. Upon the addition of urokinase, infant blood showed a remarkable decrease of antithrombin III (AT III). Levels of AT III of 100% prior to urokinase addition dropped to 40% when urokinase was added.
The conceritration of c^-antitrypsin was lowered to 70%, a 2 -macroglobulin did not change remarkably (Fig. 6) . The levels of a 2 -macroglobulin, «j-antitrypsin, and antithrombin III in the first days after delivery are shown in Fig. 4 . 
Discussion
During the newborn period two main coagulatory complications may occur: dissenmated intraväs-cular coagulation (DIC) and respiratory distress syndrome (R.D.S). Newborns who show Symptoms of R.D.S may be devided clinically äs follows:
(1) pulmonary hyaline membrane only. Summaiy "Hemorrhage in the newborn" has long been recognized äs merely a result of vitamin K deficiency. However, it is also recognized that fibrinolysis, especially the correlation between the plasminogen-activator and plasmin-inhibitors, plays an important role in this disease during the neonatal period.
With this in mind, we compared thromboelastograms (TEG) from samples with and without urokinase (plasminogen-activator). In 13 out of 15 newborn infant bloodsamples (prior to and after addition of urokinase) the thromboelastogram showed the pattern of a consumption coagulopathy.
The change in the concentration of plasmin-inhibitor during the neonatal period was also measured u sing a 2 -macroglobulin, <* r antitrypsin and antithrombin III with M-partigen-plates.
The value of o^-macroglobulin showed normal adult levels but the value of aj-antitrypsin and antithrombin III did not even reach half of the adult level. During the newborn period, the plasmin-inhibitor shows a remarkable lowering tendency and it may be surmised that with such a lowering tendenc^Vplasmin-inhibitor may constitute an exceptionally large handicap when the activator is working. This is especially true in the cases of lung hemorrhage since the activator arises from a severe pathological state in the lungs and in addition becäuse this is complicated by the lowering of plasmin-inhibitor. These results indicate that the low level of plasmin-inhibitors work synergistically with the high value of activator. The low level of antithrombin III could be the reason for coagulation disorders such äs disseminated intravasculv, coagulation, (DIC). Ces resultats indiquent que le taux reduit des inhibiteurs de plasmine agit synergistiquement avec les valeurs elevees de l'activateur. Le taux reduit de l'antithrombine III pourrait etre a l'origine de troubles de coagulation comme la coagulation intravasculaire disseminee (DIC).
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